Pollak, KI, Lyna, P, Bilheimer, A, Farrell, D, Gao, X, Swamy, GK, and Fish, LJ. "A PILOT STUDY TESTING SMS-TEXT DELIVERED SCHEDULED GRADUAL REDUCTION TO PROMOTE SMOKING CESSATION AND REDUCTION AMONG PREGNANT SMOKERS.": SPRINGER, March 1, 2013.
Geeta Krishna Swamy, MD
Dr. Geeta Swamy, MD, became Vice Chair for Research and Faculty Development in the Department of Obstetrics and Gynecology on March 1, 2018. In this dual role, Dr. Swamy oversees strategic development and administration of the Department’s basic, translational and clinical research programs, as well as implements and oversees programs to support development and mentorship for all faculty at all levels.
Dr. Swamy has dedicated her career to advancing research in women’s health and to mentoring faculty and trainees. She is an internationally recognized clinician-researcher, and an expert and nationally-recognized leader in the field of maternal immunization and vaccination in pregnancy. Her research has been funded by the National Institutes of Health (NIH), Centers for Disease Control (CDC), Environmental Protection Agency (EPA) and others. She currently serves as the Co-Principal Investigator for the NIH-NIAID Vaccine Treatment and Evaluation (VTEU) and CDC-funded Clinical Immunization Safety Assessment, and has published over 100 peer-reviewed manuscripts. Dr. Swamy has been the Director of the Duke Perinatal Research Center since 2010.
Dr. Swamy has also been instrumental in developing and leading the School of Medicine’s Research Regulatory and Compliance initiatives, first as Chair of the IRB and then as Associate Dean for Clinical Research for Regulatory Oversight and Research Initiatives. This past fall, she was promoted to Senior Associate Dean for Clinical Research in the School of Medicine.
Dr. Swamy's focused area of interests are perinatal infection, maternal immunization and preterm birth.
Education and Training
- Resident, Obstetrics And Gynecology, University of Pittsburgh, 1997 - 2001
- M.D., University of North Carolina at Chapel Hill, 1997
Selected Grants and Awards
- Population Health Research Support IDIQ Base
- VTEU A-1 Admin
- Duke CTSA (KL2)
- Duke CTSA (TL1)
- CISA 2018-2019- Clinical Consult - Opt 1
- RTOP 2018 CISA 01 Flublok Lead Base
- RTOP 2018 CISA 01 Flublok Lead Task 1
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study Capitation
- RSV- M-301
- The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
- Rapid, Near Patient Nucleic Acid Testing for Infant Cytomegalovirus (CMV) Infection
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- MFMU Network Studies
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
- Duke Research Training Program for Pediatricians
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study
- Duke CTSA (UL1)
- CISA Task Order No. 3 Tdap Safety in Pregnant Women
- DMID 05-0048 Tdap Vaccine in Pregnant Women
- DMID 09-0005 Safety and Immunogenicity
- Effectiveness of a Vaccination Program in the Community ObGyn Setting
- 09-0056 A Phase II Study in Pregnant Women to Assess H1N1 Vaccine
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant
- PiiiTCH Study
Swamy, GK, and Garcia-Putnam, R. "Vaccine-preventable diseases in pregnancy." American Journal of Perinatology 30, no. 2 (February 2013): 89-97. (Review)
Westreich, D, Rosenberg, M, Schwartz, S, and Swamy, G. "Representation of women and pregnant women in HIV research: a limited systematic review." Plos One 8, no. 8 (January 2013): e73398-null. (Review)
Sheffield, JS, Munoz, FM, Beigi, RH, Rasmussen, SA, Edwards, KM, Read, JS, Heine, RP, Ault, KA, Swamy, GK, Jevaji, I, Spong, CY, Fortner, KB, Patel, SM, and Nesin, M. "Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments." Vaccine 31, no. 40 (2013): 4264-4273.
Swamy, GK, and Garcia-Putnam, R. "Vaccine-preventable diseases in pregnancy." American Journal of Perinatology 30, no. 2 (2013): 89-97.
Edwards, SE, Miranda, ML, Neelon, BH, Paul, CJ, and Swamy, GK. "Blood Lead Levels Among Pregnant Women: Historical Versus Contemporaneous Exposures." (November 1, 2012).
Fortner, KB, Fitzpatrick, CB, Grotegut, CA, Swamy, GK, Murtha, AP, Heine, RP, and Brown, HL. "Cervical dilation as a predictor of pregnancy outcome following emergency cerclage." The Journal of Maternal Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 25, no. 10 (October 2012): 1884-1888.
Swamy, GK. "Current methods of labor induction." Seminars in Perinatology 36, no. 5 (October 2012): 348-352. (Review)
Østbye, T, Krause, KM, Stroo, M, Lovelady, CA, Evenson, KR, Peterson, BL, Bastian, LA, Swamy, GK, West, DG, Brouwer, RJN, and Zucker, NL. "Parent-focused change to prevent obesity in preschoolers: results from the KAN-DO study." Preventive Medicine 55, no. 3 (September 2012): 188-195.
Canzoneri, BJ, Grotegut, CA, Swamy, GK, Brancazio, LR, Sinclair, T, Heine, PR, and Murtha, AP. "Maternal serum interleukin-6 levels predict impending funisitis in preterm premature rupture of membranes after completion of antibiotics." The Journal of Maternal Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 25, no. 8 (August 2012): 1329-1332.